Date, Minimum Bids Set for Sale of Correlogic's Assets
May 27, 2011
Date, Minimum Bids Set for Sale of Correlogic's Assets
Auction of the company's assets is scheduled for June 17, with minimum bids set at $850,000 for its ovarian assets – which include its protein-biomarker based ovarian cancer diagnostic OvaCheck – and $1.35 million for its ovarian and non-ovarian assets combined.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Quest Seeks to Stop Sale of Correlogic's Assets, Claims Rights to OvaCheck IP
April 15, 2011 / ProteoMonitor - Correlogic Developing 'Second Generation' OvaCheck; Seeks Ruling on Quest, LabCorp Licenses
July 8, 2011 / ProteoMonitor - Court Grants Correlogic's Motion to Reject OvaCheck Licensing Agreements with Quest and LabCorp
October 8, 2010 / ProteoMonitor - Joining LabCorp, Quest Files Objection to Correlogic's Motion to Reject OvaCheck Licensing Agreements
September 3, 2010 / ProteoMonitor - Auction of Correlogic's Assets Pushed Back to Give Potential Buyers Time for Due Diligence
June 17, 2011 / ProteoMonitor